The purpose of this study is to analyze the Mexican healthcare system, comprising the following segments: pharmaceuticals and biotechnology, medical devices, healthcare IT, medical imaging, and clinical diagnostics. Revenue figures and the compound annual growth rate (CAGR) from 2011 to 2015 will be will be examined and compared to the rest of Latin America. The economic recovery and the interest of the government to create more equality are generating an increase in public healthcare expenditures. These increases will be detailed. A market overview will include a political, economic, social, and technological analysis.